Warning: The NCBI web site requires JavaScript to function. more...
Basal cytokeratins and their relationship to the cellular origin and functional classification of breast cancer.
Gusterson BA, Ross DT, Heath VJ, Stein T.
Breast Cancer Res. 2005;7(4):143-8. Epub 2005 May 5. Review.
Related citations
Basal carcinoma of the breast revisited: an old entity with new interpretations.
Korsching E, Jeffrey SS, Meinerz W, Decker T, Boecker W, Buerger H.
J Clin Pathol. 2008 May;61(5):553-60. Epub 2008 Mar 6. Review.
Do 'basal-like' breast cancers really exist?
Gusterson B.
Nat Rev Cancer. 2009 Feb;9(2):128-34. Epub 2008 Dec 29.
Immunohistochemical identification of basal-type cytokeratins in invasive ductal breast carcinoma--relation with grade, stage, estrogen receptor and HER2.
Kusińska R, Potemski P, Jesionek-Kupnicka D, Kordek R.
Pol J Pathol. 2005;56(3):107-10.
The majority of triple-negative breast cancer may correspond to basal-like carcinoma, but triple-negative breast cancer is not identical to basal-like carcinoma.
Kuroda N, Ohara M, Inoue K, Mizuno K, Fujishima N, Hamaguchi N, Lee GH.
Med Mol Morphol. 2009 Jun;42(2):128-31. Epub 2009 Jun 18.
Establishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression data.
Grigoriadis A, Mackay A, Reis-Filho JS, Steele D, Iseli C, Stevenson BJ, Jongeneel CV, Valgeirsson H, Fenwick K, Iravani M, Leao M, Simpson AJ, Strausberg RL, Jat PS, Ashworth A, Neville AM, O'Hare MJ.
Breast Cancer Res. 2006;8(5):R56.
Basal-like breast cancer and the BRCA1 phenotype.
Turner NC, Reis-Filho JS.
Oncogene. 2006 Sep 25;25(43):5846-53. Review.
In search of a stem cell hierarchy in the human breast and its relevance to breast cancer evolution.
Villadsen R.
APMIS. 2005 Nov-Dec;113(11-12):903-21. Review.
Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome.
Bergamaschi A, Tagliabue E, Sørlie T, Naume B, Triulzi T, Orlandi R, Russnes HG, Nesland JM, Tammi R, Auvinen P, Kosma VM, Ménard S, Børresen-Dale AL.
J Pathol. 2008 Feb;214(3):357-67.
Annexin A8 is up-regulated during mouse mammary gland involution and predicts poor survival in breast cancer.
Stein T, Price KN, Morris JS, Heath VJ, Ferrier RK, Bell AK, Pringle MA, Villadsen R, Petersen OW, Sauter G, Bryson G, Mallon EA, Gusterson BA.
Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6872-9.
Refinement of breast cancer classification by molecular characterization of histological special types.
Weigelt B, Horlings HM, Kreike B, Hayes MM, Hauptmann M, Wessels LF, de Jong D, Van de Vijver MJ, Van't Veer LJ, Peterse JL.
J Pathol. 2008 Oct;216(2):141-50.
Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.
Kim MJ, Ro JY, Ahn SH, Kim HH, Kim SB, Gong G.
Hum Pathol. 2006 Sep;37(9):1217-26. Epub 2006 Jul 18.
The phenotypic spectrum of basal-like breast cancers: a critical appraisal.
Fadare O, Tavassoli FA.
Adv Anat Pathol. 2007 Sep;14(5):358-73. Review.
Isogenic normal basal and luminal mammary epithelial isolated by a novel method show a differential response to ionizing radiation.
Huper G, Marks JR.
Cancer Res. 2007 Apr 1;67(7):2990-3001.
Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms.
Sørlie T, Wang Y, Xiao C, Johnsen H, Naume B, Samaha RR, Børresen-Dale AL.
BMC Genomics. 2006 May 26;7:127.
Gene expression profiling of breast cell lines identifies potential new basal markers.
Charafe-Jauffret E, Ginestier C, Monville F, Finetti P, Adélaïde J, Cervera N, Fekairi S, Xerri L, Jacquemier J, Birnbaum D, Bertucci F.
Oncogene. 2006 Apr 6;25(15):2273-84.
Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.
Rakha EA, Putti TC, Abd El-Rehim DM, Paish C, Green AR, Powe DG, Lee AH, Robertson JF, Ellis IO.
J Pathol. 2006 Mar;208(4):495-506.
Clinical and pathologic aspects of basal-like breast cancers.
Nat Clin Pract Oncol. 2008 Mar;5(3):149-59. Review.
Basoluminal carcinoma: a new biologically and prognostically distinct entity between basal and luminal breast cancer.
Laakso M, Tanner M, Nilsson J, Wiklund T, Erikstein B, Kellokumpu-Lehtinen P, Malmström P, Wilking N, Bergh J, Isola J.
Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4185-91.
p63 correlates with both BRCA1 and cytokeratin 5 in invasive breast carcinomas: further evidence for the pathogenesis of the basal phenotype of breast cancer.
Ribeiro-Silva A, Ramalho LN, Garcia SB, Brandão DF, Chahud F, Zucoloto S.
Histopathology. 2005 Nov;47(5):458-66.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on